ストックスクリーナーアプリを入手
4.61
3.13%
0.14
アフターアワーズ：
1.90
-2.71
-58.79%
前日終値:
$4.47
開ける：
$4.46
24時間の取引高:
16,855
Relative Volume:
0.44
時価総額：
$29.38M
収益：
$500.00K
当期純損益:
$-9.23M
株価収益率:
-3.0629
EPS:
-1.5051
ネットキャッシュフロー:
$-8.47M
1週間 パフォーマンス:
+4.06%
1か月 パフォーマンス:
+21.64%
6か月 パフォーマンス:
+17.60%
1年 パフォーマンス:
-65.26%
1日の値動き範囲:
$4.46
$4.70
1週間の範囲:
$4.36
$5.0661
52週間の値動き範囲:
$3.1006
$14.73
Exicure Inc Stock (XCUR) Company Profile
Compare XCUR vs PSNYW, SHMD, GOODO, DWLD, QQQE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| 0.625 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
5.30 | 493.05M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
7.42 | 364.76M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
19.92 | 372.90M | 0 | 0 | 0 | 0.00 |
DWLD
Davis Select Worldwide ETF
|
43.93 | 0 | 0 | 0 | 0 | 0.00 |
QQQE
Direxion NASDAQ-100 Equal Weigh
|
99.50 | 0 | 0 | 0 | 0 | 0.00 |
Exicure Inc Stock (XCUR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-12-13 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2020-12-18 | 開始されました | BMO Capital Markets | Outperform |
| 2019-11-20 | 開始されました | Guggenheim | Buy |
Exicure Inc (XCUR) 最新ニュース
Exicure, Inc. 2025 Annual Report: Strategic Alternatives, Financial Results, and Risk Factors Overview - Minichart
Exicure 10-K: Revenue $0.0M, EPS $(0.79) — net loss narrows to $(4.95)M - TradingView
Exicure (NASDAQ: XCUR) flags going concern, legal and listing risks - Stock Titan
Liquidity strain deepens as Exicure (NASDAQ: XCUR) posts 2025 results - Stock Titan
Exicure, Inc. Reports 2025 Financial Results and Highlights Need for Additional Financing - Quiver Quantitative
Exicure, Inc. Reports Full Year 2025 Financial Results - Bitget
Casella Waste Systems, Inc. to Present at Upcoming Investor Conference - The Manila Times
Exicure says its cash won't fund the next 12 months of operations - Stock Titan
Portfolio Update: Can Exicure Inc expand into new marketsWatch List & Technical Entry and Exit Tips - baoquankhu1.vn
Breakout Zone: Does Exicure Inc offer margin of safetyMarket Performance Report & High Conviction Buy Zone Alerts - baoquankhu1.vn
Exicure Inc Stock (ISIN: US30205M1027) Faces Uncertainty Amid Biotech Sector Volatility - AD HOC NEWS
Short Interest in Exicure, Inc. (NASDAQ:XCUR) Rises By 14.3% - Defense World
Pharma News: What is the Moat Score of Exicure IncEarnings Risk Summary & High Accuracy Trade Alerts - baoquankhu1.vn
Aug Catalysts: Is Exicure Inc stock influenced by commodity prices2026 Retail & Daily Profit Maximizing Tips - baoquankhu1.vn
(XCUR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Can Exicure Inc continue delivering strong returnsTrade Entry Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
Breakout Watch: Whats the fair value of Exicure Inc stockTreasury Yields & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Trend Review: Is Exicure Inc stock a hidden gemDay Trade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Activity Recap: Can Exicure Inc continue delivering strong returnsLayoff News & Fast Moving Market Watchlists - baoquankhu1.vn
(XCUR) Risk Channels and Responsive Allocation - Stock Traders Daily
XCUR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
David Giljohann - Crain's Chicago Business
XCUR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Exicure (XCUR) CAO has shares withheld to cover RSU taxes - Stock Titan
Exicure Announces New CEO and Interim CFO Appointments - The Globe and Mail
Bear Alert: Whats the fair value of Exicure Inc stockFed Meeting & AI Driven Price Forecasts - baoquankhu1.vn
Can Exicure Inc. continue delivering strong returnsWeekly Trade Summary & Weekly High Return Opportunities - mfd.ru
Market Pulse: Does Exicure Inc stock have upside surprise potentialJuly 2025 WrapUp & Smart Allocation Stock Reports - baoquankhu1.vn
Exicure announces board and executive changes, CEO and CFO resignations By Investing.com - Investing.com India
Exicure announces board and executive changes, CEO and CFO resignations - Investing.com Nigeria
Exicure Announces Major Leadership and Board Restructuring - TipRanks
Leadership shake-up at Exicure (NASDAQ: XCUR) as CEO, CFO and directors exit - Stock Titan
Why Exicure Inc. stock remains on watchlistsJuly 2025 Trends & Technical Pattern Recognition Alerts - mfd.ru
Can Exicure Inc. stock sustain revenue growth2025 Stock Rankings & Accurate Buy Signal Alerts - mfd.ru
Aug Intraday: What is the Moat Score of Exicure IncTrade Risk Summary & Capital Protection Trading Alerts - baoquankhu1.vn
Exicure announces publication of results from Phase 2 study of burixafor - TipRanks
Exicure (XCUR) Publishes Promising Phase 2 Study Results for Bur - GuruFocus
Exicure (XCUR) Publishes Promising Phase 2 Study Results for Burixafor - GuruFocus
Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant - The Manila Times
Exicure, Inc. Publishes Phase 2 Study Results for Burixafor, a Novel CXCR4 Inhibitor in Hematologic Disease Treatment - Quiver Quantitative
Same-day stem cell collection seen in Exicure Phase 2 cancer trial - Stock Titan
Market Catalysts: Can Exicure Inc expand into new marketsJuly 2025 Chart Watch & High Conviction Buy Zone Picks - baoquankhu1.vn
Quarterly Earnings: Should I invest in NEPH before earningsWeekly Market Outlook & Daily Profit Maximizing Tips - baoquankhu1.vn
Jobs Data: Does Exicure Inc offer margin of safetyGap Up & Verified Entry Point Detection - baoquankhu1.vn
Trade Report: What is the Moat Score of Exicure Inc2025 Sector Review & Trade Opportunity Analysis - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up - TipRanks
Market Trends: What is the Moat Score of Exicure IncJuly 2025 Update & Long-Term Safe Investment Ideas - baoquankhu1.vn
Exicure completes Phase 2 trial milestone and plans $1 million payment to GPCR Therapeutics - Investing.com UK
Exicure to Pay GPCR Therapeutics $1 Million for First Milestone Completion - 아시아경제
Exicure Inc (XCUR) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):